High Plasma Dimethylarginine Levels are Associated with Adverse Clinical Outcome After Stroke

Aim: Increased levels of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, have been observed in patients with cardiovascular risk factors and atherosclerosis and in patients with a history of stroke. The role of ADMA and its analogue symmetric dimethylarginine (S...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of Atherosclerosis and Thrombosis 2011, Vol.18(9), pp.753-761
Hauptverfasser:	Worthmann, Hans, Chen, Shufen, Martens-Lobenhoffer, Jens, Li, Na, Deb, Milani, Tryc, Anita Blanka, Goldbecker, Annemarie, Dong, Qiang, Kielstein, Jan Thomas, Bode-Böger, Stefanie Margarethe, Weissenborn, Karin
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Arginine - analogs & derivatives Arginine - blood Asymmetric dimethylarginine(ADMA) Case-Control Studies Chromatography, High Pressure Liquid Female Humans L-arginine Male Middle Aged Outcome Prospective Studies Reproducibility of Results Stroke Stroke - blood Stroke - pathology Symmetric dimethylarginine(SDMA) Tandem Mass Spectrometry
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!